Q5149 Inj, aflibercept-abzv, 1 mg

Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 4 units per day (practitioner), rationale: Anatomic Consideration